| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
| 2022 | The effects of the voglibose on non-alcoholic fatty liver disease in mice model
| SCIENTIFIC REPORTS |
| 2022 | Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Effects of a Phosphodiesterase inhibitor on the Browning of Adipose Tissue in Mice
| BIOMEDICINES |
| 2022 | Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
| FRONTIERS IN ENDOCRINOLOGY |
| 2022 | Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
| Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
| 2022 | Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
| YONSEI MEDICAL JOURNAL |
| 2022 | Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2022 | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
| BMC MEDICINE |
| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
| JAMA NETWORK OPEN |
| 2022 | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2022 | Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People | HYPERTENSION |
| 2021 | Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
| 2021 | Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2021 | Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
| DIABETES & METABOLISM JOURNAL |
| 2021 | Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2021 | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes | DIABETES OBESITY & METABOLISM |
| 2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
| DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
| 2020 | Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks | DIABETES OBESITY & METABOLISM |
| 2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
| SCIENTIFIC REPORTS |
| 2020 | Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes | DIABETES & METABOLISM |
| 2020 | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
| MEDICINE |
| 2020 | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
| DIABETES & METABOLISM JOURNAL |
| 2020 | Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
| CARDIOVASCULAR DIABETOLOGY |
| 2020 | A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus | JOURNAL OF DIABETES AND ITS COMPLICATIONS |
| 2020 | SGLT2 Inhibition Modulates NLRP3 Inflammasome Activity via Ketones and Insulin in Diabetes With Cardiovascular Disease
| NATURE COMMUNICATIONS |
| 2020 | Gamma Glutamyltransferase and Risk of Dementia in Prediabetes and Diabetes
| SCIENTIFIC REPORTS |
| 2020 | Association Between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
| DIABETES & METABOLISM JOURNAL |
| 2020 | Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2020 | Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
| Journal of Lipid and Atherosclerosis |
| 2020 | Proteinuria is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes Mellitus | TRANSPLANTATION PROCEEDINGS |
| 2019 | The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
| DIABETES THERAPY |
| 2019 | Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus
| SCIENTIFIC REPORTS |
| 2019 | Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial | DIABETES OBESITY & METABOLISM |
| 2019 | Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
| Endocrinology and Metabolism (대한내분비학회지) |
| 2019 | Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria | Journal of Diabetes and Its Complications |
| 2019 | Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors | Cancer Chemotherapy and Pharmacology |
| 2019 | Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study | Diabetologia |
| 2019 | Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide | Diabetes & Metabolism |
| 2019 | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
| DIABETES & METABOLISM JOURNAL |
| 2019 | Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM |
| 2019 | Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
| DIABETES & METABOLISM JOURNAL |
| 2019 | Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
| DIABETES & METABOLISM JOURNAL |
http://orcid.org/0000-0003-0542-2854
(7007118478)
